Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia.

OBJECTIVES To explore the clinical associations of thick melanoma and to compare the clinicopathological variables of nodular and superficial spreading types. DESIGN Cross-sectional study of all invasive primary melanomas recorded by the Victorian Cancer Registry for 1998 and those reviewed by the Victorian Melanoma Service between October 1, 1994, and April 31, 1999. SETTING Population-based cancer registry and public hospital-based multidisciplinary melanoma clinic. PATIENTS This study included 1422 patients recorded by the Victorian Cancer Registry and 674 patients who had attended the Victorian Melanoma Service; unclassifiable tumor types were excluded, leaving 1144 and 645 patients, respectively, eligible for analysis. MAIN OUTCOME MEASURES Melanomas were categorized by thickness into thin (< or =1 mm), intermediate (>1-3 mm), and thick (>3 mm) and compared according to patient age, sex, and tumor type and site. Superficial spreading and nodular types were also compared in this manner. Use of the Victorian Melanoma Service database enabled a more comprehensive analysis of historical and phenotypic characteristics. RESULTS Thick melanoma was predominantly nodular, occurring in older men, mostly on the head and neck and associated with fewer nevi. Nodular melanoma was thicker and found mostly on the lower limbs or head and neck; it had a greater association with a history of solar keratoses than did superficial spreading melanoma. CONCLUSION Nodular type and older age are the most significant associations of thick melanoma.

[1]  B. Goldman Melanoma and tumor thickness. , 2000, Archives of Dermatology.

[2]  D. Lipsker,et al.  Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. , 1999, Archives of dermatology.

[3]  D. English,et al.  Melanoma in the elderly — a neglected public health challenge , 1999, The Medical journal of Australia.

[4]  J. Grob,et al.  Melanoma and tumor thickness: challenges of early diagnosis. , 1999, Archives of dermatology.

[5]  L. Dennis,et al.  Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. , 1999, Archives of dermatology.

[6]  D. English,et al.  Nodular histogenetic type--the most significant factor for thick melanoma: implications for prevention. , 1998, Melanoma research.

[7]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[8]  J. Kelly,et al.  Melanoma in the elderly ‐a neglected public health challenge , 1998, The Medical journal of Australia.

[9]  P. Hersey,et al.  Factors involved in presentation of older people with thick melanoma , 1998, The Medical journal of Australia.

[10]  U. Ringborg,et al.  Nodular histogenetic type – the most significant factor for thick melanoma: implications for prevention , 1998, Melanoma research.

[11]  J Cuzick,et al.  Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.

[12]  J. Hunter,et al.  Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 , 1997, BMJ.

[13]  U. Ringborg Review: Cutaneous Malignant Melanoma , 1996 .

[14]  E. Nicolaidou,et al.  Cutaneous malignant melanoma and sun exposure. Recent developments in epidemiology. , 1998, Archives of dermatology.

[15]  G. Giles,et al.  Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994 , 1996, BMJ.

[16]  R. Swerlick,et al.  The melanoma epidemic. Is increased surveillance the solution or the problem? , 1996, Archives of dermatology.

[17]  Gernot Rassner,et al.  Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients , 1995, Cancer.

[18]  U. Chetty,et al.  Cutaneous malignant melanoma. Publicity, screening clinics and survival—the Edinburgh experience 1982–90 , 1995, The British journal of dermatology.

[19]  C. Luke,et al.  Trends in prognostic factors of melanoma in South Australia, 1981–1992: implications for health promotion , 1995, The Medical journal of Australia.

[20]  H. Adami,et al.  Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. , 1994, British Journal of Cancer.

[21]  R. Burton,et al.  Recent incidence trends imply a nonmetastasizing form of invasive melanoma , 1994, Melanoma research.

[22]  P. Hersey,et al.  An analysis of a melanoma epidemic , 1993, International journal of cancer.

[23]  J C Briggs,et al.  Cutaneous melanoma. , 1993, Journal of the American Academy of Dermatology.

[24]  N. Martin,et al.  Increasing incidence of cutaneous melanoma in Queensland, Australia. , 1992, Journal of the National Cancer Institute.

[25]  R. MacKie,et al.  Melanoma in people aged 65 and over in Scotland, 1979-89. , 1992, BMJ.

[26]  P. Hersey,et al.  Factors related to the presentation of patients with thick primary melanomas , 1991, The Medical journal of Australia.

[27]  R. Marks,et al.  DO ALL MELANOMAS COME FROM “MOLES”? A STUDY OF THE HISTOLOGICAL ASSOCIATION BETWEEN MELANOCYTIC NAEVI AND MELANOMA , 1990, The Australasian journal of dermatology.

[28]  A. Kopf,et al.  Age and malignant melanoma: comparison of variables in different age-groups. , 1989, Journal of the American Academy of Dermatology.

[29]  C. D. Taylor Malignant melanoma in the elderly. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  A. Kopf,et al.  Thickness of malignant melanoma: global analysis of related factors. , 1987, The Journal of dermatologic surgery and oncology.

[31]  D. English,et al.  MELANOMA IN WESTERN AUSTRALIA IN 1980‐81: INCIDENCE AND CHARACTERISTICS OF HISTOLOGICAL TYPES , 1987, Pathology.

[32]  A. Cochran,et al.  The Classification of Malignant Melanoma, its Histological Reporting and Registration: A Revision of the 1972 Sydney Classification , 1986, Pathology.

[33]  R. MacKie,et al.  The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population , 1985, The British journal of dermatology.

[34]  A. Green,et al.  Cutaneous malignant melanoma in association with other skin cancers. , 1985, Journal of the National Cancer Institute.

[35]  B K Armstrong,et al.  Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. , 1984, Journal of the National Cancer Institute.

[36]  Heenan Pj,et al.  Nodular malignant melanoma: a distinct entity or a common end stage? , 1982 .

[37]  C. Holman,et al.  Nodular malignant melanoma: a distinct entity or a common end stage? , 1982, American journal of dermatopathology.

[38]  K. Kupka,et al.  International classification of diseases: ninth revision. , 1978, WHO chronicle.

[39]  J. Hunter CUTANEOUS MALIGNANT MELANOMA , 1976, International journal of dermatology.

[40]  W. Clark,et al.  The histogenesis and biologic behavior of primary human malignant melanomas of the skin. , 1969, Cancer research.